PCSK9-IN-31
Product Specifications
UNSPSC Description
PCSK9-IN-31 (Compound WX002) is an orally active PCSK9 inhibitor. PCSK9-IN-31 can lower low-density lipoprotein cholesterol (LDL-C) and total cholesterol (TC) in high cholesterol fed model rats[1].
Target Antigen
PCSK9
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Field of Research
Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/pcsk9-in-31.html
Smiles
CC1=C(N([C@H]2CNCCC2)C(C3=CC=C(C4=NOC(C)(C)C4=O)C=C3)=O)N=CC=C1
Molecular Weight
406.48
References & Citations
[1]Wenjie Xu, et al. CRYSTAL FORM α OF COMPOUND A, PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL COMPOSITION CONTAINING CRYSTAL FORM. Patent. WO2020078170A1.
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-161942/PCSK9-IN-31-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-161942/
Clinical Information
No Development Reported
CAS Number
2247649-76-7
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
![Mouse Monoclonal ER alpha/NR3A1 Antibody (ER505) [DyLight 680]](https://cdn.genprice.uk/genprice/genprice3.png)
![Rabbit Monoclonal Gremlin 1 Antibody (117) [DyLight 755]](https://cdn.genprice.uk/genprice/genprice4.png)